Aoxiang Pharmaceutical Industry: Net profit in 2025 is 131 million yuan, a year-on-year decrease of 36.86%.

Ouxiang Pharmaceutical announced that in 2025, it achieved operating income of 793 million yuan, a year-on-year decrease of 0.32%; net profit was 131 million yuan, a year-on-year decrease of 36.86%. The company's profit distribution plan for 2025 is to distribute a cash dividend of 0.64 yuan per 10 shares to all shareholders. There will be no capital reserve transfer to increase share capital or bonus shares for this year.